Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Symptoms of Depression and Anxiety Are Independently Associated With Clinical Recurrence of Inflammatory Bowel Disease.

Mikocka-Walus A, Pittet V, Rossel JB, von Känel R; Swiss IBD Cohort Study Group..

Clin Gastroenterol Hepatol. 2016 Jun;14(6):829-835.e1. doi: 10.1016/j.cgh.2015.12.045. Epub 2016 Jan 25.

PMID:
26820402
2.

Quality of Life in Swiss Paediatric Inflammatory Bowel Disease Patients: Do Patients and Their Parents Experience Disease in the Same Way?

Mueller R, Ziade F, Pittet V, Fournier N, Ezri J, Schoepfer A, Schibli S, Spalinger J, Braegger C, Nydegger A; Swiss IBD Cohort Study..

J Crohns Colitis. 2016 Mar;10(3):269-76. doi: 10.1093/ecco-jcc/jjv199. Epub 2015 Oct 29.

3.

Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease.

Safroneeva E, Vavricka SR, Fournier N, Pittet V, Peyrin-Biroulet L, Straumann A, Rogler G, Schoepfer AM; Swiss IBD Cohort Study Group..

Aliment Pharmacol Ther. 2015 Oct;42(8):977-89. doi: 10.1111/apt.13363. Epub 2015 Aug 14.

4.

Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients.

Safroneeva E, Vavricka S, Fournier N, Seibold F, Mottet C, Nydegger A, Ezri J, Straumann A, Rogler G, Schoepfer AM; Swiss IBD Cohort Study Group..

Aliment Pharmacol Ther. 2015 Sep;42(5):540-8. doi: 10.1111/apt.13307. Epub 2015 Jul 6. Erratum in: Aliment Pharmacol Ther. 2015 Dec;42(11-12):1334.

5.

Analysis of TNF-antagonist switch over time and associated risk factors in the Swiss Inflammatory Bowel Disease Cohort.

Hiroz P, Vavricka SR, Fournier N, Safroneeva E, Pittet V, Rogler G, Schoepfer AM; Swiss Inflammatory Bowel Diseases Cohort Study Group..

Scand J Gastroenterol. 2014 Oct;49(10):1207-18. doi: 10.3109/00365521.2014.946082. Epub 2014 Aug 14.

PMID:
25120029
6.

Prevalence and clinical importance of mesenteric venous thrombosis in the Swiss Inflammatory Bowel Disease Cohort.

Violi NV, Schoepfer AM, Fournier N, Guiu B, Bize P, Denys A; Swiss Inflammatory Bowel Disease Cohort Study Group..

AJR Am J Roentgenol. 2014 Jul;203(1):62-9. doi: 10.2214/AJR.13.12447. Erratum in: AJR Am J Roentgenol. 2014 Aug;203(2):463.

PMID:
24951196
7.

Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn's disease activity.

Schaffer T, Schoepfer AM, Seibold F; Swiss IBD Cohort Study Group..

J Crohns Colitis. 2014 Sep;8(9):1125-32. doi: 10.1016/j.crohns.2014.02.014. Epub 2014 Mar 11.

PMID:
24636141
8.

The Tibetan herbal formula Padma Digestin in functional dyspepsia: an open-label study.

Meier R, Hengstler P, Weber F, Maurer H, Bommeli C, Brignoli R.

Forsch Komplementmed. 2013;20 Suppl 2:2-7. doi: 10.1159/000351086. Epub 2013 Jun 21.

9.

Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate.

Schoepfer AM, Dehlavi MA, Fournier N, Safroneeva E, Straumann A, Pittet V, Peyrin-Biroulet L, Michetti P, Rogler G, Vavricka SR; IBD Cohort Study Group..

Am J Gastroenterol. 2013 Nov;108(11):1744-53; quiz 1754. doi: 10.1038/ajg.2013.248. Epub 2013 Aug 27.

PMID:
23978953
10.

Penetrating or stricturing diseases are the major determinants of time to first and repeat resection surgery in Crohn's disease.

Pittet V, Rogler G, Michetti P, Fournier N, Vader JP, Schoepfer A, Mottet C, Burnand B, Froehlich F; Swiss Inflammatory Bowel Disease Cohort Study Group..

Digestion. 2013;87(3):212-21. doi: 10.1159/000350954. Epub 2013 May 23.

PMID:
23711401
11.

Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease: results from the Swiss Inflammatory Bowel Disease Cohort Study.

Sulz MC, Siebert U, Arvandi M, Gothe RM, Wurm J, von Känel R, Vavricka SR, Meyenberger C, Sagmeister M; Swiss IBD Cohort Study Group..

Eur J Gastroenterol Hepatol. 2013 Jul;25(7):790-7. doi: 10.1097/MEG.0b013e32836019b9.

PMID:
23571609
12.

Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: results of the swiss inflammatory bowel disease cohort study.

Siebert U, Wurm J, Gothe RM, Arvandi M, Vavricka SR, von Känel R, Begré S, Sulz MC, Meyenberger C, Sagmeister M; Swiss IBD Cohort Study Group..

Inflamm Bowel Dis. 2013 Mar-Apr;19(4):847-55. doi: 10.1097/MIB.0b013e31827f278e.

PMID:
23446333
13.

Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease.

Eloranta JJ, Wenger C, Mwinyi J, Hiller C, Gubler C, Vavricka SR, Fried M, Kullak-Ublick GA; Swiss IBD Cohort Study Group..

Pharmacogenet Genomics. 2011 Sep;21(9):559-64. doi: 10.1097/FPC.0b013e328348f70c.

PMID:
21832969
14.

Epidemiology of inflammatory bowel disease: Is there a shift towards onset at a younger age?

Braegger CP, Ballabeni P, Rogler D, Vavricka SR, Friedt M, Pittet V; Swiss IBD Cohort Study Group..

J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):141-4. doi: 10.1097/MPG.0b013e318218be35.

PMID:
21788753
15.

Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals.

Voegtlin M, Vavricka SR, Schoepfer AM, Straumann A, Voegtlin J, Rogler G, Ballabeni P, Pittet V, Buser A, Fried M, Beglinger C; Swiss IBD Cohort Study..

J Crohns Colitis. 2010 Dec;4(6):642-8. doi: 10.1016/j.crohns.2010.07.008. Epub 2010 Aug 12.

PMID:
21122574
16.

Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriateness.

Juillerat P, Pittet V, Vader JP, Burnand B, Gonvers JJ, de Saussure P, Mottet C, Seibold F, Rogler G, Sagmeister M, Felley C, Michetti P, Froehlich F; Swiss IBD Cohort Study Group..

Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1352-7. Erratum in: Eur J Gastroenterol Hepatol. 2011 Mar;23(3):294. Tempia-Caliera, Michela [corrected to Schäppi, Michela].

PMID:
20964261
17.

Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort.

Pittet V, Juillerat P, Michetti P, Vader JP, Burnand B, Rogler G, Beglinger C, Seibold F, Mottet C, Felley C, Gonvers JJ, Froehlich F; Swiss IBD Cohort Study Group..

Aliment Pharmacol Ther. 2010 Oct;32(8):1007-16. doi: 10.1111/j.1365-2036.2010.04434.x. Epub 2010 Aug 18.

18.

Capsule endoscopy: impact on clinical decision making in patients with suspected small bowel bleeding.

Gubler C, Fox M, Hengstler P, Abraham D, Eigenmann F, Bauerfeind P.

Endoscopy. 2007 Dec;39(12):1031-6.

PMID:
18072051
19.

[Check-up-examinations in internal medicine].

Hunziker S, Hengstler P, Zimmerli L, Battegay M, Battegay E.

Internist (Berl). 2006 Jan;47(1):55-65, quiz 66-7. Review. German.

PMID:
16365764
20.

Primary stenting versus primary balloon angioplasty for treating acute myocardial infarction.

Nordmann AJ, Bucher H, Hengstler P, Harr T, Young J.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD005313. Review.

PMID:
15846752

Supplemental Content

Loading ...
Support Center